BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7720110)

  • 1. [Sequence analysis of N--ras and p53 gene mutation in the human lung adenocarcinoma cell lines].
    Zhang WM; Yu H; Li WD
    Zhonghua Bing Li Xue Za Zhi; 1994 Dec; 23(6):334-7. PubMed ID: 7720110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
    Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
    Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black.
    Swafford DS; Nikula KJ; Mitchell CE; Belinsky SA
    Carcinogenesis; 1995 May; 16(5):1215-21. PubMed ID: 7539340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
    Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
    Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of K-ras oncogene mutations in human lung cancer by PCR-SSCP-DNA direct sequencing].
    Fang Q; Li X; Li J; Liang S
    Wei Sheng Yan Jiu; 1998 Jan; 27(1):6-8. PubMed ID: 10682630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The research on p53 gene mutation in lung cancer tissue of silicotic patients by PCR-SSCR].
    Zhou P; Liu B; Miao Q; Wang H
    Wei Sheng Yan Jiu; 1997 Sep; 26(5):293-5, 298. PubMed ID: 10325639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines.
    Suwa H; Yoshimura T; Yamaguchi N; Kanehira K; Manabe T; Imamura M; Hiai H; Fukumoto M
    Jpn J Cancer Res; 1994 Oct; 85(10):1005-14. PubMed ID: 7961102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
    Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
    Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutation of P53 gene in a highly metastatic human lung cancer cell line].
    Zhang B; Cui W; Gao Y
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):279-82. PubMed ID: 7587895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the N-myc oncogene in an adenocarcinoma cell line of the lung.
    Kashii T; Mizushima Y; Nakagawa K; Monno S; Yano S
    Anticancer Res; 1992; 12(3):621-4. PubMed ID: 1622116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncogene expression and point mutation in human pancreatic adenocarcinomas].
    Li DC; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):152-5. PubMed ID: 1477938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.
    Mills NE; Fishman CL; Rom WN; Dubin N; Jacobson DR
    Cancer Res; 1995 Apr; 55(7):1444-7. PubMed ID: 7882350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogen-specific mutations in the p53 tumor suppressor gene in lung cancer.
    Kandioler D; Foedinger M; Mueller MR; Eckersberger F; Mannhalter C; Wolner E
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1095-8. PubMed ID: 8159032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
    Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
    Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.
    Li ZH; Zheng J; Weiss LM; Shibata D
    Am J Pathol; 1994 Feb; 144(2):303-9. PubMed ID: 8311114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.